Back

Association of different timepoint and threshold of time-in-target-range and MACEs: insight from the SPRINT study

2 September 2024 (10:00 - 10:50)
Organised by: Logo
Congress Presentation Part of: Hypertension phenotypes Blood Pressure Measurement ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Professor Yi Zhang

Shanghai Tenth People's Hospital, Shanghai (China)

6 More presentations in this session

Presentation thumbnail
Association of cardio-cerebrovascular death with isolated diastolic hypertension: a nationally representative survey of 85, 138 adults
Professor Y. Zhang (Shanghai, CN)
Abstract Slides Video
Presentation thumbnail
Cardiovascular events risk in office-masked nocturnal hypertension defined by home blood pressure monitoring: the J-HOP nocturnal blood pressure study
Doctor T. Fujiwara (Shimotsuke, JP)
Abstract Slides Video
Presentation thumbnail
Masked hypertension is highly prevalent among patients with high-normal office blood pressure - based on the results of the Hungarian ABPM Registry
Doctor D. Pasztor (Budapest, HU)
Abstract Slides Video
Presentation thumbnail
Office, home and 24h ambulatory blood pressure monitoring in preeclampsia and uncomplicated hypertension in pregnancy
Slides Video
Presentation thumbnail
Invasive validation of central blood pressure measurements using a suprasystolic monitor
Professor S. Carlier (Mons, BE)
Abstract Slides Video

Access the full session

Session thumbnail
Hypertension phenotypes

The Event

Event poster

ESC Congress 2024

2 September 2024 10:00 CET
You may be interested in
thumbnail
Congress Presentation
Unleashing the potential: early evaluation of blood pressure control with novel measurements in patients with hypertension
thumbnail
Congress Presentation
Systolic blood pressure time in target range and cardiovascular disease and premature death
thumbnail
Congress Presentation
Association of systolic blood pressure time in target range with heart failure risk and mediating roles of NT-proBNP, hs-cTnI, and eGFR: novel findings from the SPRINT trial

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources